Key China COVID-19 examination delivered results that affected ensuing exploration on Covid Kumar Jeetendra | September 18, 2020 Crucial China COVID-19 study produced results that Affected subsequent research on coronavirus Early in the start of the COVID-19 pandemic, a small study in China produced results that affected subsequent research on the virus. Researchers at the University of Cincinnati used the same research parameters on a much larger patient population and reached completely different …
BioMed X Institute Announces Expansion of their Strategic Collaboration with Janssen in Immunology Research Kumar Jeetendra | November 9, 2020 HEIDELBERG, Germany, November 09, 2020 / B3C newswire / — German independent research institute BioMed X adds a further research program in the field of immunology to their existing collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson: The new project will focus on the development of …
Research investigate how the current practice of nephrology may have bigoted philosophies Kumar Jeetendra | January 31, 2021 There is a growing awareness of systematic inequality and structural racism in American society. Science and medicine are no exception, as evidenced by historical cases of discrimination and overt racism. In a perspective piece in the Journal of the American Society of Nephrology, researchers from Boston University School of Medicine (BUSM), take an honest look …
FDA supports new medication for therapy of adults with chronic kidney infection Kumar Jeetendra | May 1, 2021 Today, the U.S. Food and Drug Administration accepted Farxiga (dapagliflozin) oral tablets to decrease the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Chronic kidney disease occurs when the kidneys are damaged and can’t filter blood …
Nano-bubbles containing ACE2 protein can hinder contamination from wide strains of SARS-CoV-2 Kumar Jeetendra | January 21, 2022 Northwestern Medicine and The University of Texas MD Anderson Cancer Center discovered that natural nano-bubbles containing ACE2 protein (evACE2) were found in the blood of COVID-19 victims. They also discovered that these particles could block infection by broad strains of SARS/CoV-2 virus. Scientists said that the evACE2 acts in the body as a decoy and …
